Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) Stock Price, Quote & AI Analysis
Live PHAR stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Pharming Group N.V. ADS, each representing 10 ordinary shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Pharming Group N.V. ADS, each representing 10 ordinary shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Pharming Group N.V. ADS, each representing 10 ordinary shares Overview
Company information
Company Overview
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Pharming Group N.V. ADS, each representing 10 ordinary shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...